Bioabsorbable Stents Market Size, Share, Growing Trends and Forecast 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Bioabsorbable Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global bioabsorbable stents market growth, share, size, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Industry Overview of Bioabsorbable Stents Market

Bioabsorbable stents, also known as biodegradable stents or fully resorbable stents, are thin scaffold-like structures inserted into blocked or constricted coronary arteries to restore blood flow. They are available as polymeric stents constructed from biocompatible polymers like polylactic acid (PLA) or polyglycolic acid (PGA). They are also manufactured as metallic alloy-based stents coated with a bioabsorbable polymer, which controls the release of medication to prevent restenosis. They are made from materials that degrade over time, allowing the artery to regain its natural function, unlike traditional metal stents that remain permanently in the body. They are designed to provide mechanical support to narrowed or blocked arteries while gradually dissolving within the body, eliminating the long-term presence of foreign materials. They serve as an alternative to metallic stents, which can cause complications such as in-stent restenosis and thrombosis. They allow for easier navigation and treatment of the vessel in potential future interventions due to the absence of a permanent implant. Bioabsorbable stents are utilized in the treatment of coronary artery disease (CAD), a condition characterized by the building up of plaque within the arteries, leading to lowered blood flow to the heart. They are employed in cases where the condition necessitates the eventual restoration of natural vascular function.

How Big Is the Bioabsorbable Stents Market?

The global bioabsorbable stents market size reached US$ 379.1 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 620.2 Million by 2028, exhibiting a growth rate (CAGR) of 8% during 2023-2028.

Global Bioabsorbable Stents Market Trends and Drivers:

At present, the increasing demand for bioabsorbable stents as they eliminate the risks associated with permanent metallic implants, reducing the likelihood of in-stent restenosis and thrombosis over time, represents one of the crucial factors impelling the growth of the market. Besides this, the rising employment of bioabsorbable stents, as they enable the artery to regain its natural flexibility and movement, which is vital for proper blood flow and overall cardiovascular health, is contributing to the growth of the market. In addition, the growing demand for bioabsorbable stents, as they do not obscure imaging techniques such as magnetic resonance imaging (MRI), facilitating more accurate assessment during follow-up procedures, is offering a favorable market outlook. Apart from this, the increasing occurrence of cardiovascular diseases among the geriatric population and among individuals who indulge in excessive smoking is supporting the growth of the market. Additionally, rising advancements in the manufacturing of various innovative biocompatible polymers with enhanced structural integrity and overall therapeutic efficacy are strengthening the growth of the market. Moreover, the increasing employment of minimally invasive (MI) surgical procedures as it reduces the duration of hospitalization, and the cost of medical bills is propelling the growth of the market. Furthermore, the rising construction of various hospitals and clinics to provide quality healthcare services to patients is bolstering the growth of the market.

What Is Included In Market Segmentation?

The report has been segmented the market into following categories:

Breakup by Biomaterial:

• Polymer-based Bioabsorbable Stents
• Metal-based Bioabsorbable Stents

Breakup by Absorption Rate:

• Slow-Absorption Stents
• Fast-Absorption Stents

Breakup by Application:

• Coronary Artery Disease
• Peripheral Artery Disease

Breakup by End User:

• Hospitals
• Cardiac Centers

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The report provides a comprehensive analysis of the industry key players listed below:

The Major Players in the market are The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arterius Limited, B. Braun SE, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Reva Medical LLC and Terumo Corporation.